METTL21ABAG3

Ping Zhan1, Yizhe Cheng1, Yingcan Wu1

  • 1Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.

PubMed
概括

甲基转移酶21A (METTL21A) 通过抑制蛋白质降解来驱动肝细胞癌 (HCC) 的生长. 用sophoricoside向METTL21A为HCC提供了一个潜在的新疗法.